Iasis Molecular Sciences seeks collaborations with leading researchers and top medical centers to accelerate the development and rapid translation of our first-in-class product candidates into first-in-human clinical evaluations. We believe these collaborations will maximize our potential to identify state of the art products in areas of wound healing, antimicrobial devices, performance coatings and decorative paints. Our products are aimed at minimizing pathogen transmission in a variety of different environments, and as additives specific for minimizing fouling in marine environments. Additionally, we believe our proprietary platforms can be deployed in collaboration with strategic partners to create unique products and co-develop state of the art therapies.
Advanced Medical Solutions (AMS), Cheshire, United Kingdom
Iasis Molecular Sciences has entered a Material Transfer Agreement in 2018 with AMS to develop Advanced Wound Care Foams at the pilot scale level. The AMS Group of companies specialize in the design, development, manufacture and distribution of novel, high performance advanced wound care products, surgical dressings and medical grade materials.
Dr. Hassan Razvi, MD Chief of Urology, St. Joseph’s Health Care and the London Health Sciences Centre, London ON, CN.
The collaboration with Dr. Razvi as of October 2016, followed an award from the Congressionally-Directed Medical Research Program of the Department of the Army. The collaborative investigator-initiated research project is directed toward the development of a next generation urinary catheter utilizing Iasis Molecular Sciences Platform No. 2 antimicrobial composite technology. Dr. Razvi is the author of over 130 scientific papers and 13 book chapters and is currently Professor and Chair of the Division of Urology at The University of Western Ontario and Chief of Urology at St. Joseph’s Health Care London and the London Health Sciences Centre.
Dr. Jeremy Burton PhD. Assistant Professor, Division of Urology, Western University, London Ontario CN also Scientist with Lawson Health Research Institute
The collaboration with Dr. Burton as of October 2016, followed an award from the Congressionally-Directed Medical Research Program of the Department of the Army. The collaborative investigator initiated research project is directed toward the development of a next generation urinary catheter utilizing Iasis Molecular Sciences Platform No. 2 antimicrobial composite technology. Dr. Burton’s laboratory conducts research on the role of microbes in various human conditions with a primary focus upon the microbiome which influences urological conditions. Dr. Burton’s team brings expertise in the area of microbiology, cell culture, and the evaluation of biofilm associated infection.
Hydromer Inc., Branchburg Township, New Jersey (New Collaboration)
IMS has entered into a collaboration with Hydromer Inc. to develop antimicrobial lubricious coatings using Iasis Molecular Sciences Platform No. 1 antiseptics. The first application will be for test articles related to the Iasis Molecular Sciences next generation urinary catheter.
Bentec Medical, Woodland California
Iasis Molecular Sciences has signed a letter of intent with Bentec Medical. They are currently producing a few different prototypes, including a catheter prototype. These prototypes will be studied and coated for our Department of Defense program.
Dr. George Bonheyo, Senior Research Scientist and the Biotechnology Team Lead in the Energy and Environment Directorate at Pacific Northwest National Laboratory’s Marine Sciences Laboratory in Sequim, Washington
Dr. Bonheyo’s expertise is in the areas of the molecular basis of pathogenesis, biofilms and biofouling, biocorrosion has led to collaborations with Iasis Molecular Sciences directed at marine antifouling and coatings solutions to microbial contamination in the clinical environment. At present, Dr. Bonheyo has a number of Iasis Molecular Sciences generated test panels under evaluation for a Department of Energy funded wave to energy program as well as for below water line vessel coatings.
Global Paints and Performance Coatings Manufacturer
Iasis Molecular Sciences is involved in a collaboration with a global paints and performance coatings manufacturer with interest in the use of our Platform No. 2 antimicrobials as an additive for marine paints to minimize marine fouling. Presently, testing is underway in two distinct marine fouling environments.
Dr. Dorne Yager PhD – Virginia Commonwealth University (VCU)
Dr. Yager has collaborated with Iasis Molecular Sciences on a variety of projects sponsored by the NIH and the D.O.D.. Dr. Yager has been involved in the wound healing field and has acted as the Director of the VCU Plastic Surgery Research Laboratory since 1990. He has broad experience with design and execution of preclinical models for wound healing. His laboratory utilizes a variety of molecular, biochemical and histological assays to assess wound repair events with a focus on inflammation. Dr. Yager’s collaborations have produced several peer-reviewed publications from his various projects.